Kirk Garratt, MD, medical director of the Center for Heart and Vascular Health, ChristianaCare, and a past president of SCAI, explains what this shortage means for interventional cardiologists.

“We need to commit to changing the supply chain so that a single event in a faraway country does not put us in this predicament again," experts wrote in a new special report shared by Radiology.

Two separate sessions presented at SCAI 2022 focused on long-term outcomes associated with Shockwave Medical's IVL technology.

Randall Thompson, MD, immediate past president of the American Society of Nuclear Cardiology (ASNC), explains two key advances in cardiac nuclear imaging.
 

The COVID lockdowns at the Shanghai plant began on March 31, and although the plant there has since resumed operations, they are not yet at 100% capacity.

All-cause mortality after one year was 4.6% for the TAVR group and 6.6% for the SAVR group

Terry Bowers, MD, director of vascular medicine at Beaumont Hospital and national co-chair of the Pulmonary Embolism Research Collaborative (PERC), explains the trend toward creating pulmonary embolism (PE) response teams that include cardiology. 

Two late-breaking clinical trials at EuroPCR 2022 in Paris focused on the potential benefits of renal denervation.